176 related articles for article (PubMed ID: 12740666)
1. Two cases of cerebral aspergillosis successfully treated with voriconazole.
de Lastours V; Lefort A; Zappa M; Dufour V; Belmatoug N; Fantin B
Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):297-9. PubMed ID: 12740666
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of brain aspergillosis with voriconazole.
Tattevin P; Bruneel F; Lellouche F; de Broucker T; Chevret S; Wolff M; Régnier B
Clin Microbiol Infect; 2004 Oct; 10(10):928-31. PubMed ID: 15373890
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Stiefel M; Reiss T; Staege MS; Rengelshausen J; Burhenne J; Wawer A; Foell JL
Pediatr Blood Cancer; 2007 Aug; 49(2):203-7. PubMed ID: 16333861
[TBL] [Abstract][Full Text] [Related]
5. Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
Ehrmann S; Bastides F; Gissot V; Mercier E; Magro P; Bailly E; Legras A
Intensive Care Med; 2005 May; 31(5):738-42. PubMed ID: 15782314
[TBL] [Abstract][Full Text] [Related]
6. Intravenous voriconazole after toxic oral administration.
Alffenaar JW; van Assen S; de Monchy JG; Uges DR; Kosterink JG; van der Werf TS
Antimicrob Agents Chemother; 2010 Jun; 54(6):2741-2. PubMed ID: 20385853
[TBL] [Abstract][Full Text] [Related]
7. Neuroaspergillosis in an immunocompetent patient successfully treated with voriconazole and a corticosteroid.
Hiraga A; Uzawa A; Shibuya M; Numata T; Sunami S; Kamitsukasa I
Intern Med; 2009; 48(14):1225-9. PubMed ID: 19602790
[TBL] [Abstract][Full Text] [Related]
8. [A case of resistant pulmonary and cerebral aspergillosis successfully treated with voriconazole].
Uçan ES; Avkan Oğuz V; Güngör O; Gülşen A; Uğural Sezak N; Tertemiz KC; Ceylan E; Kargi A; Balci P; Ada E; Sanli A
Tuberk Toraks; 2006; 54(1):75-9. PubMed ID: 16615023
[TBL] [Abstract][Full Text] [Related]
9. Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole.
Gubler C; Wildi SM; Imhof A; Schneemann M; Müllhaupt B
Infection; 2007 Oct; 35(5):364-6. PubMed ID: 17721739
[TBL] [Abstract][Full Text] [Related]
10. Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
Chow E; Moore T; Nielsen K
Pediatr Infect Dis J; 2003 Dec; 22(12):1109-10. PubMed ID: 14688580
[TBL] [Abstract][Full Text] [Related]
11. Resolution of orbitocerebral aspergillosis during combination treatment with voriconazole and amphotericin plus adjunctive cytokine therapy.
Bethell D; Hall G; Goodman TR; Klein N; Pollard AJ
J Pediatr Hematol Oncol; 2004 May; 26(5):304-7. PubMed ID: 15111783
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia.
Lassaletta A; Perez A; Díaz MA; Sevilla J; González-Vicent M; Madero L
J Pediatr Hematol Oncol; 2004 Feb; 26(2):117-9. PubMed ID: 14767202
[No Abstract] [Full Text] [Related]
13. Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review.
Stratov I; Korman TM; Johnson PD
Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):277-83. PubMed ID: 12734721
[TBL] [Abstract][Full Text] [Related]
14. Improved outcome in central nervous system aspergillosis.
Tattevin P; Le Tulzo Y
Blood; 2006 Apr; 107(8):3410-1; author reply 3411-2. PubMed ID: 16597600
[No Abstract] [Full Text] [Related]
15. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L
Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.
Elter T; Sieniawski M; Gossmann A; Wickenhauser C; Schröder U; Seifert H; Kuchta J; Burhenne J; Riedel KD; Fätkenheuer G; Cornely OA
Int J Antimicrob Agents; 2006 Sep; 28(3):262-5. PubMed ID: 16908120
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of voriconazole metabolism by chloramphenicol in an adolescent with central nervous system aspergillosis.
Hafner V; Albermann N; Haefeli WE; Ebinger F
Antimicrob Agents Chemother; 2008 Nov; 52(11):4172-4. PubMed ID: 18794387
[TBL] [Abstract][Full Text] [Related]
18. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
19. Treatment of primary aspergilloma of the central nervous system in a diabetic immunocompetent patient with surgical resection and voriconazole: a case report and review of the literature.
Koshy R; Malhotra P
Turk Neurosurg; 2011; 21(4):641-4. PubMed ID: 22194129
[TBL] [Abstract][Full Text] [Related]
20. Increasing the dose of voriconazole compensates for enzyme induction by phenytoin.
Spriet I; Meersseman P; Meersseman W; de Hoon J; Willems L
Br J Clin Pharmacol; 2010 Jun; 69(6):701-2. PubMed ID: 20565462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
